Pyridinyl and pyrazinyl-(asa)indolsulfonamides

US11939319B2 · kind B2 · utility

Assignee

• UCB Pharma GMBH · DE

Inventors

• Cecile Pegurier · Uccle - Ukkel, BE
• Laurent Provins · Soignies, BE
• Alvaro Cardenas · Tervuren, BE
• Marie Ledecq · Éghezée, BE
• Christa E. Mueller · Bonn, DE
• Joerg Hockemeyer · Bonn, DE
• Ali El-Tayeb · Bonn, DE
• Nader M. BOSHTA · Bonn, DE
• Mahmoud Rashed · Bonn, DE

Key dates

• Filing date: Jun 18, 2019
• Grant date: Mar 26, 2024
• Expiry date: Mar 3, 2041

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D471/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides having GPR17 modulator activity. The compounds have utility in the treatment of a variety of GPR17-associated disorders.